KaydedilenlerDerginizi ekleyin

Dergiler / BEYOGLU EYE JOURNAL / 2020 / Cilt: 5 - Sayı: 3

Effectiveness of Selective Laser Trabeculoplasty as Initial or Adjunctive Treatment for Primary Open-Angle Glaucoma

Halil İbrahim YENER
Muammer ÖZÇİMEN
Sayfa
199–204
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The reduction in IOP was similar in the primary and adjunctive group for up to 1 year of follow-up.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The aim of this study was to evaluate the effectiveness of selective laser trabeculoplasty (SLT) at lowering intraocular pressure (IOP) as initial or adjunctive treatment in patients with primary open-angle glaucoma (POAG).Methods: This was a prospective, comparative study.
📊
Temel Bulgular & Veri:A total of 162 eyes of 81 patients with bilateral POAG were eval-uated.
💡
Sonuç & Katkı:The reduction in IOP was similar in the primary and adjunctive group for up to 1 year of follow-up.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: The aim of this study was to evaluate the effectiveness of selective laser trabeculoplasty (SLT) at lowering intraocular pressure (IOP) as initial or adjunctive treatment in patients with primary open-angle glaucoma (POAG).Methods: This was a prospective, comparative study. A total of 162 eyes of 81 patients with bilateral POAG were eval-uated. The patients were categorized into 2 groups. SLT was performed as an adjunctive treatment in 42 POAG patients (Group 1, 84 eyes) and as initial treatment in 39 POAG patients (Group 2, 78 eyes).Results: The mean baseline IOP and post-SLT IOP for the entire study group was 23.3±4.8 mm Hg and 14.6±2.7 mm Hg, respectively. The mean percentage reduction of IOP post-SLT at the final visit was 34.5% in Group 1 and 40.5% in Group 2. The number of medications used in the Group 1 before SLT was 2.11±0.88 (range: 1-4), while after SLT, medication use decreased to 0.9 ±0.15 (range: 0-3). The mean length of follow-up was 49.85±8.2 weeks (range: 24-78 weeks).Conclusion: SLT can be used effectively as a primary or an adjunctive therapy for the treatment of POAG. It was also effective at reducing the quantity of medications used. The reduction in IOP was similar in the primary and adjunctive group for up to 1 year of follow-up.

🔖

Bu Makaleye Atıf Yap

YENER, H. İ., ÖZÇİMEN, M. (2020). Effectiveness of Selective Laser Trabeculoplasty as Initial or Adjunctive Treatment for Primary Open-Angle Glaucoma. BEYOGLU EYE JOURNAL, Cilt: 5 - Sayı: 3, 199–204. https://ajindex.com/articles/348275

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treat-ment: the early manifes glaucoma trial. Arch Ophthalmol 2003;121:48–56
  2. Realini T. Selective laser trabeculoplasty for the management of open-angle glau-coma in St. Lucia. JAMA Ophthalmol 2013;131:321–7
  3. Khouri AS, Lari HB, Berezina TL, Maltzman B, Fechtner RD. Long term efficacy of re-peat selective laser trabeculoplasty. J Ophthalmic Vis Res 2014;9:444–8
  4. Wang H, Cheng JW, Wei RL, Cai JP, Li Y, Ma XY. Meta-analysis of selective laser trabeculoplasty with argon laser trabeculoplasty in the treatment of open-angle glaucoma. Can J Ophthalmol 2013;48:186–92
  5. Lowry EA, Greninger DA, Porco TC, Naseri A, Stamper RL, Han Y. A comparison of resident performed argon and selective laser trabeculoplasty in patients with open-angle glaucoma. J Glaucoma 2016;25:e157–61
  6. Latina MA, Tumbocon JAJ. Selective laser trabeculoplasty: a new treatment option for open angle glaucoma. Curr Opin Ophthalmol 2002;13:94–6
  7. Woo DM, Healey PR, Graham SL, Goldberg I. Intraocular pressure-lowering medica-tions and long-term outcomes of selective laser trabeculoplasty. Clin Experiment Ophthalmol 2015;43:320–7
  8. Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthal-mology 2001;108:773–9
  9. Latina MA, Sibayan SA, Shin D, Noecker RJ, Marcellino G. Q-switched 532-nm Nd: YAG lasertrabeculoplasty (selective laser trabeculoplasty): A multicenter, pilot, clini-cal study. Ophthalmology 1998;105:2082–8
  10. Gracner T. Intra ocular pressure response to selective laser trabeculoplasty in the treatment of primary open-angle glaucoma. Ophthalmologica 2001;215:267–70
  11. Qian SH, Sun XH. Selective laser trabeculoplasty in the treatment of primary open-angle glaucoma. ZhonghuaYi Xue Za Zhi 2007;87:118–20
  12. Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot study. Arch Ophthalmol 2003;121:957–60
  13. McIlraith I, Strasfeld M, Colev G, Hutnik CM. Selective laser trabeculoplasty as initial and adjunctive treatment for open angle glaucoma. J Glaucoma 2006;15:124–30
  14. Nagar M, Ogunyomade A, O'Brart DP. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of